Clinical trial Recruiting at 1 site Interventional Ages 30 to 75

Investigating how different starch types affect glucose metabolism in overweight adults

Official title: Personalized Metabolic Responses to Rapid, Slow and Resistant Starch (PerStarch)

Run by Chalmers University of Technology · NCT06897241 · Data updated 2026-11-12

This study is testing how different types of starch affect blood sugar levels in overweight adults with different gut bacteria and gene variations.

Quick facts

Study typeInterventional
Ages30 Years to 75 Years
SexAll
Enrollment96 (estimated)
SponsorChalmers University of Technology
Academic / other
Locations1 site (Gothenburg, Västra Götaland County)
StatusRecruiting
StartedApril 8, 2025
Main results expectedMay 1, 2026
Study endsMay 1, 2026
Registry record updatedMay 16, 2025
Trial IDNCT06897241 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are men and post-menopausal women aged 30-75 with a BMI between 27-40 kg/m2.

Probably not a fit

Patients with diabetes, recent cardiovascular events, or significant gastrointestinal conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines the metabolic responses of individuals with varying gut microbiota and AMY1 gene copy number to three types of starch: resistant, slow digestible, and rapid digestible. Over a 12-week period, participants will undergo a randomized, cross-over feeding intervention, where they will consume each type of starch for 14 days, separated by wash-out periods. Blood, saliva, and fecal samples will be collected to analyze glucose metabolism and gut microbiota composition. Participants will also complete questionnaires regarding their dietary intake, lifestyle, and health-related quality of life.

Why it matters

Potential benefit: If successful, this study could lead to personalized dietary recommendations for improving glucose metabolism in overweight and obese individuals.

How similar studies have gone: While there is ongoing research into personalized nutrition based on gut microbiota, this specific approach to starch types and glucose metabolism is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men and post-menopausal women
* Age 30-75 years
* BMI 27-40 kg/m2
* Waist circumference \> 102/88 cm for men/women
* Weight stable during previous 3 months (± 3 kg)
* Willingness to consume the intervention diets
* Ability to deal with the monitoring devices
* Medications stable for the previous 14 days
* Signed informed consent

Exclusion Criteria:

* Cardiovascular events (myocardial infarction or stroke) during the previous 6 months
* Diagnosis of diabetes (any type) or use of any drug who can interfere with glucose homeostasis (i.e., metformin, incretin analogues, SGLT-2 inhibitors)
* History of stomach or gastrointestinal conditions (inflammatory bowel disease, Crohn's disease, malabsorption, etc.)
* Colostomy, bowel resection, bariatric surgery or other major gastrointestinal surgery
* Renal or liver failure (creatinine \<1.7 mg/dl and alanine aminotransferase/aspartate aminotransferase \< 2 times than normal values, respectively)
* Anemia (hemoglobin below the age and sex specific normal reference ranges at screening)
* Blood donation (or participation in a clinical study with blood sampling) within 30 days prior to inclusion
* Having been treated with antibiotics within the past 3 months or planning to undergo treatment during the study period.
* Habitual use of probiotic/prebiotic supplements or foods enriched in probiotics
* Celiac disease
* Vegan/vegetarian diet (or a diet incompatible with protocol diets)
* Intense physical activity regimen (\> 7 h/week of moderate intensity or \> 3 h/week of high intensity)
* History of drug or alcohol abuse
* Not able to understand written and spoken Swedish
* Any other reason for lack of suitability for participation in the trial, as judged by the principal investor or co-principal investigator

Where it's running

  • Clinical Trial Center, Sahlgrenska University Hospital
    Gothenburg, Västra Götaland County, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.